Related Experiment Videos
Schizophrenia and single-carbon metabolism
1Institute of Clinical Neuroscience, Göteborg University, Sweden. bjorn.regland@vgregion.se
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|August 13, 2005
Summary
Schizophrenia patients show altered single-carbon metabolism, with many having elevated methionine and some with high homocysteine. Nutritional interventions like B-vitamins may offer new treatment avenues.
Area of Science:
- Biochemistry
- Neuroscience
- Psychiatry
Background:
- Single-carbon metabolism is frequently disturbed in schizophrenia.
- Methionine and homocysteine are key intermediary metabolites in this pathway.
Purpose of the Study:
- To investigate single-carbon metabolism in schizophrenia patients.
- To explore potential nutritional interventions for schizophrenia.
Main Methods:
- A case-control study design was employed.
- Cerebrospinal fluid samples were analyzed.
- Levels of methionine and homocysteine were measured.
Main Results:
- A majority of schizophrenia patients exhibited elevated methionine levels.
- A subgroup of patients presented with elevated homocysteine.
- Elevated homocysteine may be linked to folate dependency and MTHFR gene mutations.
Conclusions:
- Schizophrenia is associated with disruptions in single-carbon metabolism.
- Nutritional factors, including B-vitamins and antioxidants, show promise for schizophrenia prevention and treatment.
- Further research into nutrient-based therapies for schizophrenia is warranted.